Intellia Therapeutics Stock Overlap Studies Parabolic SAR

NTLA Stock  USD 15.62  0.41  2.70%   
Intellia Therapeutics overlap studies tool provides the execution environment for running the Parabolic SAR study and other technical functions against Intellia Therapeutics. Intellia Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Parabolic SAR study function is designed to identify and follow existing trends. Intellia Therapeutics overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Acceleration Factor and AF Maximum to execute this module.

The output start index for this execution was one with a total number of output elements of sixty. The Parabolic SAR indicator is used to determine the direction of Intellia Therapeutics's momentum and the point in time when Intellia Therapeutics has higher than normal probability directional change.

Intellia Therapeutics Technical Analysis Modules

Most technical analysis of Intellia Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Intellia from various momentum indicators to cycle indicators. When you analyze Intellia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Intellia Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Intellia Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Intellia Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Intellia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Intellia Therapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Intellia Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Intellia Therapeutics, we also check how macroeconomic factors affect Intellia Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding22.4326.39366.82385.16
PTB Ratio8.062.172.582.74
Hype
Prediction
LowEstimatedHigh
10.9915.4219.85
Details
Intrinsic
Valuation
LowRealHigh
14.0632.0236.45
Details
Naive
Forecast
LowNextHigh
12.3116.7321.16
Details
30 Analysts
Consensus
LowTargetHigh
75.7683.2592.41
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run AI Portfolio Architect Now

   

AI Portfolio Architect

Use AI to generate optimal portfolios and find profitable investment opportunities
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Business Services Idea
Business Services
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 60 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Momentum Idea
Momentum
Invested over 200 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Banking Idea
Banking
Invested over 40 shares
Video Games Idea
Video Games
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
When determining whether Intellia Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intellia Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intellia Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intellia Therapeutics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Intellia Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Intellia Stock refer to our How to Trade Intellia Stock guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intellia Therapeutics. If investors know Intellia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intellia Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.45)
Revenue Per Share
0.449
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.28)
Return On Equity
(0.52)
The market value of Intellia Therapeutics is measured differently than its book value, which is the value of Intellia that is recorded on the company's balance sheet. Investors also form their own opinion of Intellia Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Intellia Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intellia Therapeutics' market value can be influenced by many factors that don't directly affect Intellia Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intellia Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Intellia Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intellia Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.